期刊文献+

去铁胺对促进扩张后皮瓣微循环重建的实验研究

Experimental study on promoting reconstruction of microcirculation of expanded skin flap with defemxamine
下载PDF
导出
摘要 目的探讨去铁胺(Defemxamine,DFX)对扩张后皮瓣微循环重建的影响。方法将新西兰大耳白兔24只分成实验组和对照组,兔额部皮下植入圆柱形扩张器,制备蒂部位于耳根的矩形皮瓣,实验组分别于模型制备后即刻、第3天、第5天将DFX注射于皮瓣末端,对照组皮下注射等量的生理盐水,第7天分别进行皮瓣平均微血管数目及内径、皮瓣组织中超氧化物歧化酶(MDA)、丙二醛(SOD)含量及血管内皮生长因子(VEGF)mRNA检测。结果实验组皮瓣SOD含量、VEGFmRNA表达高于对照组(P<0.05),平均微血管数目多于对照组(P<0.05),平均微血管内径及MDA含量小于对照组(P<0.05)。结论在扩张皮瓣的局部注射DFX,可以降低自由基水平,加快新生血管形成并促进皮瓣微循环重建。 Objective To investigate the effects of Deferoxamine (DFX) on the reconstruction of microcircu-lation of expanded skin flap. Methods A total of 24 rabbits were divided r andomly into experimental groups and control group. The cylindrical expander was implanted into frontal subcutaneous of the rabbits and rectangular pedicle skin flap was prepared. In the experimental group, the end of the flap was injected with DFX (100 mg/kg) immediate-ly, 3rd and 5th days respectively after the model of preparation;The same dose of normal saline was injected in the con-trol group. On day 7, the mircrovessels was evaluated under the microscope, activity of superoxide dismutase (SOD),content of malondialdehyde (MDA) and VEGF mRNA expression were measured. Result Compared with the con-trol group, SOD activity and Vascular endothelial cell growth factor (VEGF) mRNA expression rised, microvascular density increased (P〈0.05), MDA content and microvascular diamete decreased in the experimental groups (P〈0.05). Conclusion DFX can reduce oxygen free radicals level and accelerate angiogenesis to promote reconstruction of mi-crocirculation of expanded skin flap.
出处 《海南医学》 CAS 2014年第9期1259-1261,共3页 Hainan Medical Journal
基金 东莞市科技局科研立项(编号:20121051059233)
关键词 去铁胺 扩张皮瓣 丙二醛 超氧化物歧化酶 血管内皮生长因子 Defemxamine Expanded skin flap Malondialdehyde Superoxide dismutase Vascular endotheli-al cell growth factor
  • 相关文献

参考文献9

  • 1Moridani MY, Pourahmad J, Bui H, et al. Dietary flavonoid ironcomplexes as cytoprotective superoxide radical scavengers [J].Free Radic Biol Med, 2003, 34(2): 243 -253.
  • 2Hamrick SE, McQuillen PS, Jiang X. A role for hypoxia -induciblefactor 1 alpha in desferoxamine neuroprotection [J]. Neurosci Lett,2005,379(2): 96-100.
  • 3Prada FS, Arrunategui G, Alves MC, et al. Effect of allopurinol, su-peroxide-dismutase, and hyperbaric oxygen on flap survival [J]. Mi-cro Surgery, 2002, 22 (8): 352-360.
  • 4陈暧,周玫.自由基医学[M].北京:人民卫生出版社,1993:13-54, 142-145.
  • 5韩雪峰,李健宁,杨大平,聂春磊,刘国锋,郭铁芳,郝晨光,马辉,谷守滨.跨区供血皮瓣成活过程中血管构筑及内源性VEGF变化的实验研究[J].中国美容医学,2008,17(2):232-234. 被引量:6
  • 6Huang N,Khan A, Ashraour H, et al. Efficacy and mechanism ofadenovirus-mediated VEGF-165 gene therapy for augmentation ofskin flap viability [J]. Am J Physiol Heart Circ Physiol, 2006, 291(1): 127-137.
  • 7Langlois A, Bietiger W, Maudes K, et al. Overexpression of vascu-lar endothelial growth factor in vitro using deferoxamine: a newdrug to increase islet vascularization during transplantation [J],Transplant Proc, 2008, 40(2): 473 -476.
  • 8Hamrick SE, McQuillen PS, Jiang X. A role for hypoxia - induciblefactor 1 alpha in desferoxam -ine neuroprotection [J], NeurosciLett, 2005, 379(2): 96-100.
  • 9Prass K, Ruscher K, Karsch M, et al. Desferrioxamine induces de-layed tolerance against cerebral ischemia in vivo and in vitro [J]. JCereb Blood Flow Metab, 2002,22(5): 520-525.

二级参考文献10

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部